Boston Scientific accounts are for healthcare professionals only.
Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.
My Boston Scientific account
Access your online applications and manage your customer profile.
Quick Links
Call customer care
The Boston Scientific endoscopic retrograde cholangiopancreatography (ERCP) portfolio was designed to help physicians achieve their clinical goals.
Dr. Carr-Locke, Dr. Gromski, Dr. Adler, and Dr. Widmer are paid consultants of Boston Scientific.
Hear from Dr. Carr-Locke, Dr. Gromski, Dr. Adler, and Dr. Widmer about how they invest in clinical data research and the value it brings to their clinical practice.
The Boston Scientific comprehensive ERCP portfolio has been extensively studied – providing physicians access to devices that are supported by clinical data.
140+
publications reported on SpyGlass DS since 2015*
80+
clinical studies highlighted the impact of SpyGlass DS since 2015
The first and only biliary metal stent in the U.S. with a benign indication.**
Access comprehensive ERCP educational resources with EDUCARE. Enhance your clinical expertise, stay updated on advancements, and engage with field experts.
Indications for use: WallFlex Biliary RX Stent System, WallFlex Biliary PLUS RX Stent System: indicated for use in the palliative treatment of biliary strictures produced by malignant neoplasms and relief of malignant biliary obstruction prior to surgery.
WallFlex Biliary RX Stent System RMV: indicated for use in the palliative treatment of biliary strictures produced by malignant neoplasms, relief of malignant biliary obstruction prior to surgery, and for indwell up to 12 months in the treatment of benign biliary strictures secondary to chronic pancreatitis.
Warning: The safety and effectiveness of this device for use in vascular system has not been established
*Data on file with Boston Scientific.
**As of July 2025. The WallFlex Biliary RX Fully Covered Stent System RMV is indicated treatment of benign biliary strictures secondary to chronic pancreatitis.
***Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
1. Bruno MJ, Beyna T, Carr-Locke D, et al. Global prospective case series of ERCPs using a single-use duodenoscope. Endoscopy. 2023;55:1103–1114. Sponsored in part by Boston Scientific.
2. Muthusamy VR, Bruno MJ, Kozarek RA, et al. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2020;18:2108–2117.e3. Sponsored in part by Boston Scientific.
3. Bang JY, Hawes R, Varadarajulu S. Equivalent performance of single-use and reusable duodenoscopes in a randomised trial. Gut. 2021;70:838–844.
4. Napoléon B, Gonzel JM, Grandval P, et al. Evaluation of the performances of a single-use duodenoscope: Prospective multi-center national study. Dig Endosc. 2022;34:215–221.
5. Slivka A, Ross AS, Sejpal DV, et al. Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexity. Gastrointest Endosc. 2021;94:1046–1055.
6. Shahid HM, Bareket R, Tyberg A, et al. Comparing the safety and efficacy of two commercially available single-use duodenoscopes: A multicenter study. J Clin Gastroenterol. 2023;57:798–803.
7. Persyn D, Van Malenstein H, Vanderschueren E, et al. Performance and applicability of a first-generation single-use duodenoscope: A single-center cohort study. Ann Gastroenterol. 2022;35:368–375.
Caution: U.S. Federal law restricts these devices to sale by or on the order of a physician.
